
Internet Medical Health Media
As the healthcare industry enters a “value realization phase,” innovation is no longer scarce; what is truly scarce are validated high-quality assets and efficient connections that facilitate transactions. Over the past year, licensing-out deals for domestically developed innovative drugs have continued to rise in value, while “first-of-its-kind” achievements in innovative medical devices have emerged continuously. The logic of capital markets has shifted from prioritizing scale to prioritizing value. The industry is moving beyond storytelling to competing on clinical evidence, commercialization capabilities, and global expansion prowess.
In this context,2026 Future Healthcare & Pharma Top 100 ConferenceNo longer just a “trend exchange platform,” but further upgraded into a surrounding“Showcasing, Trading, and Empowering Innovative Assets in China’s Healthcare Sector”— the core platform that makes projects visible, matches needs, and enables real collaboration.
This conference is organized byVCBeatHosted by, to be held onMay 19–21, 2026—Held at the Platinum Hanjue Hotel in Minhang District, Shanghai. The conference centered on“Forum + Selection + Matchmaking”Three Core Pillars: Featuring a Main Forum, Hot-Track Special Sessions, an Innovative Asset Exhibition Zone, and a 1-on-1 Precision Matchmaking Area, to Seamlessly Connect Key Stages from Exhibition and Networking to Transaction Conversion.

Conference Convergence360+ academicians, clinical experts, corporate leaders, and partners from top-tier investment institutionsCentered on the goal of “making transactions happen,” we systematically deconstruct the end-to-end logic of medical innovation assets—from discovery and valuation to pricing and transaction—facilitating more efficient matching and collaboration between innovative enterprises, industry buyers, and investment institutions.
Attendees

More speakers to be announced...
From analyzing global medical innovation trends to practical breakdowns of niche sectors; from full-cycle IPO services to cross-border investment and asset transactions; from brain-computer interfaces,Medical AI Large Language Models, to key areas such as ophthalmic innovation, the global expansion of pharmaceuticals and medical devices, and out-of-hospital markets—this agenda covers multidimensional topics including macro trends, industry practices, and capital pathways. It centrally showcases new assets, new transactions, and new ecosystems in the healthcare sector for the year, serving as a vital gateway for spotting innovations, seeking partnerships, and facilitating deals.
Here, what you see is not just an agenda, but a comprehensive map of medical innovation deals.
Main Forum
Main Forum [Trends]
May 19, 09:00–12:00

Main Forum [Strategy Section]
May 19, 14:00–17:50

Main Forum [IPO Services]
Supporting Organizations: Hong Kong Biotechnology Organization (HKBIO), CEIBS Alumni Healthcare Industry Association
May 20, 09:00–12:00

Main Forum [Value Investment]
May 20, 14:00-17:30

Hot Tracks Sub-Forum
May 19
Forum on the Development of Medical AI and Large Model Applications
Co-hosted by: Probes Capital
09:00-12:00

Smart Hospital Innovation and Development Forum
09:05-12:00

Forum on International Market Expansion for Pharmaceuticals and Medical Devices
Supporting Organizations: China Chamber of Commerce for Import and Export of Medicines and Health Products, Global Health Economics Branch of the Chinese Society of Health Economics, Shanghai Biopharmaceutical Science and Technology Industry Promotion Center, PwC China, LinkedIn China
09:15-17:45


Pharmaceutical Companies Digital Marketing Forum
Co-organized by: Health Road
09:00-12:00

Vascular Intervention Innovation and Investment Forum
Co-organized by: Bestwise
09:05-12:00

Brain-Computer Interface Industry Innovation and Investment Forum
—Focusing on a Global Perspective and Ecosystem Building
Co-organized by: Guotai Haitong Policy and Industry Research Institute
14:00-17:00

Panlin Capital Special Forum on Innovative Biopharmaceutical and Medical Device R&D
Co-organized by: Panlin Capital
14:00-17:40

Forum on Tackling the “Last Mile” of Value Realization for Innovative Drugs
14:00-18:10

May 20
Ophthalmology Innovation and Investment Forum
——Focusing on Myopia Prevention and Control and the Ecosystem of the Optometry Industry
Co-organized by: Vision Medical
Supported by: Danlu Capital, Frost & Sullivan
09:00-12:00

Brain-Computer Interface Industry Innovation andInvestment Forum
——Focusing on Clinical Breakthroughs in Vision Restoration and the Launch of the Industry
Co-organized by: Mingshi Brain-Computer Interface
09:00-12:00

Forum on the Application and Investment of Imaging Equipment and Core Components
09:00-12:00

Forum on Chronic Disease Management and Health Insurance Innovation
09:00-12:00

Integrated Oncology Diagnosis and Treatment Innovation and Investment Forum
09:00-12:00

Ophthalmology Innovation and Investment Forum
— Focusing on Frontier Technological Innovations and Industrial Translation in Ophthalmology
Supporting Organization: GTJA Investment
14:00-17:10

Brain-Computer Interface Industry Innovation and Investment Forum
——Focusing on Technological Breakthroughs and Commercialization Pathways
Co-organized by: Qifeng Capital
14:00-17:00

Respiratory Sleep Health Innovation and Investment Forum
Co-organizer: Jiuhao Capital
14:00-17:00

AI-Empowered Medical Achievement Translation Salon
Co-organizer: Vision Capital
14:00-17:30

May 21
Forum on the Hong Kong Stock Market for Innovative Drugs: Trends and Opportunities
Co-organized by: Hong Kong Biotechnology Organization (HKBIO), JLL
09:00-12:20

Brain-Computer Interface Industry Innovation and Investment Forum
—Focusing on Industrial Chain Collaboration
Co-organized by: China Academy of Information and Communications Technology
09:00-12:00

Premium Asset Promotion Conference
Supporting Organizations: Yangtze River Delta National Innovation Center, FreeS Fund, Bohe Angel, Jiuhao Capital, Qisheng Capital, Shangjun Investment
10:00-16:30

Medical Humanities Keynote Forum
09:00-16:00
